DORON THERAPEUTICS, INC. logo

DORON THERAPEUTICS, INC.

4 Marks
Corp.
First Filed:Jan 26, 2020Latest Filed:Mar 3, 2025Address:2021 South Lakeshore Drive, Chapel Hill, NC 27514

Portfolio Overview

Top Classes

Class 5
Pharmaceuticals
4(100%)

TTAB Proceedings

No litigation activity

Top Firms

Loading...

Trademark Portfolio

4 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
MOTYS
MOTYS
Trademark
Word
ABANDONED
Owner:
Serial:99064240
Filed:Mar 3, 2025
Classes:5
Description: Biologic preparations, substances, and biosimilars derived from micronized, lyophilized, placental tissue particulate used for the treatment of joint and knee diseases and disorders; Biologic preparations, substances, and biosimilars for the treatment of musculoskeletal diseases, joint diseases, arthritis, and osteoarthritis
MOTYS
MOTYS
Trademark
Combined
ABANDONED
Owner:
Serial:99064245
Filed:Mar 3, 2025
Classes:5
Description: Biologic preparations, substances, and biosimilars derived from micronized, lyophilized, placental tissue particulate used for the treatment of joint and knee diseases and disorders; Biologic preparations, substances, and biosimilars for the treatment of musculoskeletal diseases, joint diseases, arthritis, and osteoarthritis
MOTYS
MOTYS
Trademark
Combined
REGISTERED
Owner:
Serial:88821335
Filed:Mar 4, 2020
Classes:5
Registration:8052375
Registered:Dec 2, 2025
Description: Biologic preparations, substances, and biosimilars derived from micronized, lyophilized, placental tissue particulate used for the treatment of joint and knee diseases and disorders; Biologic preparations, substances, and biosimilars for the treatment of musculoskeletal diseases, joint diseases, arthritis, and osteoarthritis
MOTYS
MOTYS
Trademark
Word
REGISTERED
Owner:
Serial:88773636
Filed:Jan 26, 2020
Classes:5
Registration:8052373
Registered:Dec 2, 2025
Description: Biologic preparations, substances, and biosimilars derived from micronized, lyophilized, placental tissue particulate used for the treatment of joint and knee diseases and disorders; Biologic preparations, substances, and biosimilars for the treatment of musculoskeletal diseases, joint diseases, arthritis, and osteoarthritis